NRX Pharmaceuticals, Inc.

0.18 USD
+0.01 (+9.37%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NRX Pharmaceuticals, Inc. stock is up 9.38% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 April’s closed higher than March.

About NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure.